Atea Pharmaceuticals

About:

Atea Pharmaceuticals focuses on the discovery and development of next-generation therapeutics for severe human viral infections.

Website: https://www.ateapharma.com/

Twitter/X: ateapharma

Top Investors: Perceptive Advisors, RA Capital Management, Bain Capital Life Sciences, Cormorant Asset Management, Rock Springs Capital

Description:

Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses. Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.

Total Funding Amount:

$283M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2014-01-01

Founders:

Jean Sommadossi

Number of Employees:

51-100

Last Funding Date:

2020-05-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai